Impetigo in a population over 8.5 years: Incidence, fusidic acid resistance and molecular characteristics

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 6, 2011, Pages 1360-1364

  Rørtveit, Sverre ^a,b   Skutlaberg, Dag Harald ^c   Langeland, Nina ^b   Rortveit, Guri ^b,d  

^a Municipal Health Services of Austevoll   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d Research Unit for General Practice   (Norway)

Author keywords

Clone; Fusidic acid resistance; Population based; S. aureus

Indexed keywords

FUSIDIC ACID;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; EPIDEMIC; GENERAL PRACTITIONER; HUMAN; IMPETIGO; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; NORWAY; PHENOTYPE; POPULATION RESEARCH; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FUSIDIC ACID; HUMANS; IMPETIGO; INCIDENCE; MOLECULAR TYPING; NORWAY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 79956000564     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr102     Document Type: Article

References (12)

1. Rørtveit S, Rortveit G. Impetigo in epidemic and nonepidemic phases: an incidence study over 41/2 years in a general population. Br J Dermatol 2007; 157: 100-5.
2. Lannergård J, Norström T, Hughes D. Genetic determinants of resistance to fusidic acid among clinical bacteremia isolates of Staphylococcus aureus. Antimicrob Agents Chemother 2009; 53: 2059-65.
3. Tveten Y, Jenkins A, Kristiansen BE. A fusidic acid-resistant clone of Staphylococcus aureus associated with impetigo bullosa is spreading in Norway. J Antimicrob Chemother 2002; 50: 873-6.
4. Osterlund A, Eden T, Olsson-Liljequist B, et al. Clonal spread among Swedish children of a Staphylococcus aureus strain resistant to fusidic acid. Scand J Infect Dis 2002; 34: 729-34.
5. El-Zimaity D, Kearns AM, Dawson SJ, et al. Survey, characterization and susceptibility to fusidic acid of Staphylococcus aureus in the Carmarthen area. J Antimicrob Chemother 2004; 54: 441-6.
6. Larsen AR, Skov RL, Jarlier V, et al. Epidemiological differences between the UK and Ireland versus France in Staphylococcus aureus isolates resistant to fusidic acid from community-acquired skin and soft tissue infections. J Antimicrob Chemother 2008; 61: 589-94.
7. O'Neill AJ, Larsen AR, Henriksen AS, et al. A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates. Antimicrob Agents Chemother 2004; 48: 3594-7.
8. Zinn CE, Salmelinna S, Fussing V, et al. A multicenter study in Denmark, Finland, Sweden and Norway: reproducibility of methicillin-resistant Staphylococcus aureus (MRSA) typing by standardized pulsed-field gel electrophoresis. In: Abstracts of the Ninth International Symposium on Staphylococci and Staphylococcal Infections, Kolding, Denmark, 2000. Abstract 90, p. 88. Copenhagen, Denmark.
9. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-9.
10. Harmsen D, Claus H, Witte W, et al. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 2003; 41: 5442-8.
11. Alsterholm M, Flytström I, Bergbrant IM, et al. Fusidic acid-resistant Staphylococcus aureus in impetigo contagiosa and secondarily infected atopic dermatitis. Acta Derm Venereol 2010; 90: 52-7.
12. NORM/NORM-VET 2008. http://www.vetinst.no/nor/Forskning/Publikasjoner/Norm-Norm-Vet-rapporten/Norm-Norm-Vet-rapporten-2008 (11 December 2010, date last accessed).